Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Survival Analysis01:21

Cancer Survival Analysis

862
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
862
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriers.

NPJ breast cancer·2026
Same author

The sequelae of the COVID-19 pandemic on maternal body mass index, gestational weight gain, and delivery-associated birth complications: a nationwide epidemiologic study.

BMC public health·2026
Same author

Comparing early-onset sepsis risk: risk calculator, American Academy of Pediatrics guidelines, and local care.

Pediatric research·2026
Same author

Updated ENIGMA recommendations for reporting germline variants in cancer susceptibility genes and their translation into twenty languages.

Journal of medical genetics·2026
Same author

Is Genetic Testing of HER2-Negative Metastatic Breast Cancer Patients Implemented into Clinical Practice? A Retrospective Analysis.

Journal of clinical medicine·2026
Same author

Management of Bone-Only Progressive Disease in Metastatic Breast Cancer-A Retrospective Single-Center Analysis.

Journal of clinical medicine·2026

Related Experiment Video

Updated: Apr 28, 2026

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.0K

Modern Risk Assessment for Individualizing Treatment Concepts in Early-stage Breast Cancer.

Alex Farr1, Rachel Wuerstlein2, Annika Heiduschka3

  • 1Breast Center (Comprehensive Cancer Center), Department of Gynecology and Obstetrics, Medical University of Vienna, Vienna, Austria.

Reviews in Obstetrics & Gynecology
|June 13, 2014
PubMed
Summary

Biomarker tests help personalize early-stage breast cancer treatment. These markers identify patients who can avoid chemotherapy, reducing toxic side effects and optimizing endocrine therapy decisions.

Keywords:
BiomarkersBreast cancerGene testsNeoadjuvantPrediction

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.3K
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

6.2K

Related Experiment Videos

Last Updated: Apr 28, 2026

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.0K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.3K
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

6.2K

Area of Science:

  • Oncology
  • Genomics
  • Personalized Medicine

Background:

  • Validated prognostic and predictive factors are crucial for early-stage breast cancer treatment planning.
  • Personalized medicine drives the search for individual patient markers to optimize treatment regimens.

Purpose of the Study:

  • To review current biomarker assessment methods for early-stage breast cancer.
  • To discuss the role of biomarkers in predicting chemotherapy benefit, particularly in endocrine-sensitive disease.

Main Methods:

  • Review of state-of-the-art biomarker assessment techniques.
  • Analysis of clinicopathologic measures, scores, and gene tests for risk prediction.
  • Focus on endocrine-sensitive breast cancer in neoadjuvant and adjuvant settings.

Main Results:

  • Biomarkers can identify patients at low risk of recurrence, potentially avoiding toxic therapies.
  • Gene tests and scores offer independent risk prediction in various treatment settings.
  • Challenges remain in selecting patients for endocrine therapy alone.

Conclusions:

  • Biomarker assessment is key to optimizing treatment for early-stage breast cancer.
  • Identifying patients who benefit from endocrine therapy alone is a critical clinical challenge.
  • Further research into predictive biomarkers can refine chemotherapy decisions and improve patient outcomes.